GlomCon
8,941 posts
Image
user avatar
GlomCon
@GlomCon
GlomCon is a resource for the kidney community to exchange ideas, learn, educate, and collaborate on projects. Membership via my.glomcon.org
glomcon.org
Joined May 2016
935
Following
16.1K
Followers
  • Pinned
    user avatar
    GlomCon
    @GlomCon
    Jun 10, 2025
    🚨 NOW OPEN: Pre-Application for Rare Kidney Disease/Glomerular Disease Centers of Excellence! 🚨 Join exceptional institutions, clinics, and healthcare organizations to become designated Centers of Excellence. 🎯 What you'll gain: ✅ Access to premier fellowship programs ✅
    Image
    12K
  • user avatar
    GlomCon
    @GlomCon
    Nov 22, 2023
    #KidneyWk had tons of exciting advances in glomerular diseases. Because it is more than one can absorb in a limited time, we have gone through all GN-related talks, presentations, and abstracts and will share some highlights here over the next few weeks here 🧵👇
    57K
  • user avatar
    GlomCon
    @GlomCon
    Mar 3, 2022
    Check out this Infographic about lupus nephritis by Dr. Ana Naidas @AnaNaidas a GlomCon Virtual Glomerular Disease Fellow and Nephrologist at Philippine General Hospital, Philippines
    Image
  • user avatar
    GlomCon
    @GlomCon
    Dec 11, 2023
    A comprehensive summary in 5 min 👇 PROTECT Study in IgAN by Dr. Jonathan Barratt @IgAN_JBarratt ➡️Study design ➡️Patient characteristics ➡️Intervention ➡️Outcomes ➡️Interpretation reachmd.com/programs/cme/p…
    Image
    84K
  • user avatar
    GlomCon
    @GlomCon
    Jun 23, 2020
    ⚡️Are you a nephrology fellow or early career nephrologist? GlomCon is now accepting applications for the first class of its virtual glomerular disease fellowship. Work with an elite group of expert faculty. Learn, teach and network! Apply now at edu.glomcon.org
    Image
  • user avatar
    GlomCon
    @GlomCon
    Dec 11, 2023
    A frequent question: Can you sparsentan and SGLT2i be combined, and do they provide additive benefits? The PROTECT Open-Label Extension (OLE) Substudy and SPARTACUS is aiming to answer this question 👇 asn-online.org/education/kidn…
    Image
    79K
  • user avatar
    GlomCon
    @GlomCon
    Sep 25, 2020
    We are delighted to announce the first class for our virtual Glomerular Diseases Fellowship Program. Join us in welcoming 52 amazing fellows from 19 countries! #GlomFellows #FutureExperts #NephTwitter @SaynaNorouzi @BetterCallSeeth @nephrologista @poyanmehr
    Image
    00:00
  • user avatar
    GlomCon
    @GlomCon
    Dec 11, 2023
    A comprehensive summary in 5 min 🚨 PROTECT Study in IgAN by Dr. Jonathan Barratt @IgAN_JBarratt Study design 👉Patient characteristics 👉Intervention 👉Outcomes 👉Interpretation reachmd.com/programs/cme/p…
    Image
    89K
  • user avatar
    GlomCon
    @GlomCon
    Mar 5, 2025
    Anticoagulant-related nephropathy by Dr. Irene Martin, Dr. Paolo Nikolai So, Dr. Tiffany Caza and Dr. Mohamed Hassanein Read here 👉 pubs.glomcon.org/anticoagulant-… #GlomCon
    Image
    12K
  • user avatar
    GlomCon
    @GlomCon
    Oct 21, 2022
    Lupus Nephritis Treatment – What is Next? A review of new treatments, therapeutic targets, and clinical trials by Dr. Sayali B. Thakare @SayaliBThakare in GlomCon Pubs pubs.glomcon.org/lupus-nephriti…
    Image

New to X?

Sign up now to get your own personalized timeline!

Create account

By signing up, you agree to the Terms of Service and Privacy Policy, including Cookie Use.

Terms of Service|Privacy Policy|Cookie Policy|Accessibility|Ads info|© 2026 X Corp.
Don't miss what's happening
People on X are the first to know.
Log inSign up
Advertisement
Advertisement